Uncategorised - European Medical Journal

Lung adenocarcinoma plasticity and cellular reprogramming in non-small cell lung cancer.

Cell Reprogramming Drives Lung Cancer Resistance

Lung adenocarcinoma plasticity may drive progression and treatment resistance through TP53-linked developmental reprogramming, new data suggest.

9 Jun 2026

Case by Case: Real-World Management of Acne Vulgaris

These case studies examine different presentations of acne vulgaris, including acne unmasked after OCP cessation, breakthrough nodulocystic…

Injectable pen

Boehringer posts mixed obesity drug phase 3 results

Despite the positive efficacy data, investor attention has turned to survodutide’s tolerability profile.

8 Jun 2026

HRRm Testing in mCRPC

Homologous recombination repair gene-mutated (HRRm) biomarker testing is important to plan future treatment decisions in certain patients…

Researchers Uncover Brain’s Hidden Waste Disposal System

New research mapped the brain’s hidden clearance network, revealing how neuronal proteins exit the brain and how disease can disrupt these pathways.

Maveed Sattar

Diabetes Prevention

Naveed Sattar, Professor of Cardiometabolic Medicine at the University of Glasgow, UK, discusses how diabetes, obesity, and cardiovascular…

Advances in Migraine Management

When I first heard people talk about migraine, there were two things that struck me as odd about the vascular theory. The first was that…

Most Adults Falling Short of Flavanol Intake for Cardiovascular Health

Even those who regularly consume five portions of fruit and vegetables per day may be falling short of the recommended flavanol intake, new research has found.

Antidiabetic Drugs Reduce Urinary E. coli Biofilms

Two antidiabetic medications inhibited urinary E. coli growth, reduced biofilm formation, and suppressed virulence associated gene expression in vitro.

Patient holding wrist during psoriatic arthritis flare and treatment discussion

Psoriatic Arthritis Treatment Choice After TNF Inhibitor Failure

Psoriatic arthritis treatment strategies showed comparable retention and safety after tumor necrosis factor inhibitor failure.